Vaccine effectiveness in patients admitted for influenza during the 2023-2024 season

被引:0
|
作者
Martinez, Christian Ruzafa [1 ,2 ,3 ]
Valero, Salvador [1 ,2 ,3 ]
Villalba, Eva Garcia [1 ,2 ,3 ]
Tomas, Cristina [1 ,2 ,3 ]
Munoz, Angeles [1 ,2 ,3 ]
Alcaraz, Antonia [1 ,2 ,3 ]
Martinez-Rodriguez, Rodrigo [1 ,2 ,3 ]
Hernandez, Maria Dolores [1 ,2 ,3 ]
Martinez, Maria Isabel [1 ,2 ,3 ]
Vicente, Maria Rosario [4 ]
Westermeyer, Elena Guijarro [1 ,2 ,3 ]
Hipolito, Roman Gonzalez [1 ,2 ,3 ]
Bernal, Enrique [1 ,2 ,3 ]
机构
[1] Hosp Gen Univ Reina Sofia, Secc Enfermedades Infecciosas, Murcia, Spain
[2] Inst Murciano Invest Biosanitaria Pascual Parrilla, Inmunol Microbiol & Enfermedades Infecciosas, Murcia, Spain
[3] Univ Murcia, Fac Med, Dept Med Interna, Murcia, Spain
[4] Hosp Gen Univ Reina Sofia, Serv Microbiol, Murcia, Spain
来源
MEDICINA CLINICA | 2024年 / 163卷 / 12期
关键词
Flu; Vaccine; Effectiveness; Intensive Care; Mortality;
D O I
10.1016/j.medcli.2024.07.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and goal: Vaccination against influenza is widespread worldwide, reducing complications associated with infection. However, the impact of vaccination on mortality/ICU admission in hospitalized patients has been little studied. Material and methods: A retrospective observational study was conducted on 238 patients hospitalized for influenza from October 2023 to January 2024 to evaluate the vaccine's effectiveness in terms of the combined event of ICU admission/mortality during hospitalization. Additionally, the characteristics of vaccinated patients and the existence of bacterial superinfection were analyzed. Cox regression was performed using the SPSS program and the free << R >> software. Results: A total of 238 patients were included. Those vaccinated were older (78.2 f 8.8 vs 69.97 f 16.6 years; P < .001) and were more likely to have hypertension (82.2% vs 56.2%; P < .001), cardiovascular disease (36.6% vs 24.1%; P = .05), chronic bronchopathy (25.7% vs 8.8%; P = .001), or chronic kidney disease (22.8% vs 8.8%; P = 0.005). They had lower levels of CRP (8.39 f 9.55 vs 11.03 f 10.75 mg/dl; P = .05), procalcitonin (0.62 f 1.74 vs 1.67 f 4.57 ng/dl; P = .05), and SOFA scores (1.13 f 0.9 vs 1.39 f 0.97; P = 0.033). 11 patients were admitted to ICU (4.6%) and 11 died (4.6%). Influenza vaccination was associated as a protective factor against ICU admission/mortality in the Cox regression (HR = 0.216; 95% CI: 0.0620.759, P = .017). The presence of bacterial superinfection was similar between vaccinated and unvaccinated patients (63.4% vs 67.9%; P = .556). Conclusions: Influenza vaccination may reduce the probability of ICU admission or death. This effect is likely due to better control of the immune response. We did not observe any relationship with the risk of presenting bacterial superinfection. (c) 2024 Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 50 条
  • [21] Antiviral Drugs for Influenza for 2023-2024 (vol 65, pg 177, 2023)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 192 - 192
  • [22] Circulation of influenza viruses in the dog population in Kazakhstan (2023-2024)
    Glebova, Tatyana I.
    Klivleyeva, Nailya G.
    Saktaganov, Nurbol T.
    Shamenova, Mira G.
    Lukmanova, Galina, V
    Baimukhametova, Assem M.
    Baiseiit, Sagadat B.
    Ongarbayeva, Nuray S.
    Orynkhanov, Kanat A.
    Ametova, Anna, V
    Ilicheva, Aitolkyn K.
    OPEN VETERINARY JOURNAL, 2024, 14 (08) : 1896 - 1904
  • [23] Influenza Virus Genomic Surveillance, Arizona, USA, 2023-2024
    Maqsood, Rabia
    Smith, Matthew F.
    Holland, LaRinda A.
    Sullins, Regan A.
    Holland, Steven C.
    Tan, Michelle
    Barrera, Gabrielle M. Hernandez
    Thomas, Alexis W.
    Islas, Mario
    Kramer, Joanna L.
    Nordstrom, Lora
    Mulrow, Mary
    White, Michael
    Murugan, Vel
    Lim, Efrem S.
    VIRUSES-BASEL, 2024, 16 (05):
  • [24] CDC changes recommendations due to severe nirsevimab shortage during the 2023-2024 RSV season
    Rahmat, Zainab Syyeda
    Ahmad, Shkaib
    Malikzai, Abdullah
    PEDIATRIC PULMONOLOGY, 2024, 59 (04) : 1108 - 1109
  • [25] Molecular Characterization of Respiratory Syncytial Virus Infections in Elderly Patients During the 2023-2024 Season in the Era of Nirsevimab Introduction
    Caillault, Amandine
    Softic, Laurent
    Bay, Pierre
    Ly, Arnaud
    Soulier, Alexandre
    Melica, Giovanna
    Rodriguez, Christophe
    de Prost, Nicolas
    Pawlotsky, Jean-Michel
    Fourati, Slim
    JOURNAL OF INFECTIOUS DISEASES, 2025,
  • [26] End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal
    Kislaya, Irina
    Torres, Ana Rita
    Gomes, Licinia
    Melo, Aryse
    Machado, Ausenda
    Henriques, Camila
    Verdasca, Nuno
    Guiomar, Raquel
    Rodrigues, Ana Paula
    Natl Influenza Surveillance Network
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [27] Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season - Chile, 2022
    Barraza, Maria Fernanda Olivares
    Fasce, Rodrigo A.
    Nogareda, Francisco
    Marcenac, Perrine
    Mallegas, Natalia Vergara
    Alister, Patricia Bustos
    Loayza, Sergio
    Chard, Anna N.
    Arriola, Carmen Sofia
    Couto, Paula
    Calavaro, Christian Garcia
    Rodriguez, Angel
    Wentworth, David E.
    Cuadrado, Cristobal
    Azziz-Baumgartner, Eduardo
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (43): : 1353 - 1358
  • [28] Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024
    Xie, Yan
    Choi, Taeyoung
    Al-Aly, Ziyad
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (22): : 1963 - 1965
  • [29] Influenza Vaccine Effectiveness During the 2012 Influenza Season in Victoria, Australia: Influences of Waning Immunity and Vaccine Match
    Sullivan, Sheena G.
    Komadina, Naomi
    Grant, Kristina
    Jelley, Lauren
    Papadakis, Georgina
    Kelly, Heath
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (06) : 1017 - 1025
  • [30] Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season
    McLean, Huong Q.
    Caspard, Herve
    Griffin, Marie R.
    Poehling, Katherine A.
    Gaglani, Manjusha
    Belongia, Edward A.
    Talbot, H. Keipp
    Peters, Timothy R.
    Murthy, Kempapura
    Ambrose, Christopher S.
    VACCINE, 2017, 35 (20) : 2685 - 2693